Tropomyosin-related kinase A (TrkA) inhibition for the treatment of painful knee osteoarthritis: results from a randomized controlled phase 2a trial
<p><strong>Objective</strong> To investigate the TrkA inhibitor, ASP7962, for treatment of painful knee osteoarthritis.</p> <p><strong>Design</strong> Phase 2a, double-blind, placebo- and naproxen-controlled, double-dummy, parallel-group study. Adults with...
Auteurs principaux: | Watt, F, Blauwet, M, Fakhoury, A, Jacobs, H, Smulders, R, Lane, N |
---|---|
Format: | Journal article |
Langue: | English |
Publié: |
Elsevier
2019
|
Documents similaires
-
Influenza A virus activates cellular Tropomyosin receptor kinase A (TrkA) signaling to promote viral replication and lung inflammation.
par: Vikram Verma, et autres
Publié: (2022-09-01) -
The oncogenic neurotrophin receptor tropomyosin-related kinase variant, TrkAIII
par: Antonietta Rosella Farina, et autres
Publié: (2018-06-01) -
Radioligands for Tropomyosin Receptor Kinase (Trk) Positron Emission Tomography Imaging
par: Ralf Schirrmacher, et autres
Publié: (2019-01-01) -
The Receptor Tyrosine Kinase TrkA Is Increased and Targetable in HER2-Positive Breast Cancer
par: Nathan Griffin, et autres
Publié: (2020-09-01) -
Hypofunctional TrkA Accounts for the Absence of Pain Sensitization in the African Naked Mole-Rat
par: Damir Omerbašić, et autres
Publié: (2016-10-01)